New Brunswick has taken steps to make Paxlovid more affordable for some people at higher risk of becoming severely ill or dying from COVID-19, now that the federal government has stopped supplying the anti-viral medication to provinces for free. 

But the drug designed to reduce symptoms from an infection and shorten the period of illness remains out of reach for many, either because of the cost of about $1,400 for a five-day course, a lack of timely access, or reduced eligibility.

The province no…